The study, “Structural Proteomics: An Opportunity Overview for Investors,” by John Sullivan, is now available through Multex at http://www.multexusa.com/products.asp, for $300. The study provides an overview of the field of structural proteomics, including recent technology developments and an analysis of company valuations. Sullivan is a drug discovery analyst at Stephens.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.